# Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer

> **NCT02730416** · PHASE2 · COMPLETED · sponsor: **Nordic Society of Gynaecological Oncology - Clinical Trials Unit** · enrollment: 146 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Nintedanib or Placebo; Carboplatin, Paclitaxel

## Key facts

- **NCT ID:** NCT02730416
- **Lead sponsor:** Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2021-10-20
- **Final completion:** 2021-11-25
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730416, "Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02730416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*